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Periportal and perivenous hepatocytes differ in their metabolism of blood glutamate (Glu). Uncertainty 
about the mechanisms of Glu blood-liver exchange led us to characterise, by paired-tracer dilution, a sodi- 
um-dependent dicarboxylate transporter (resembling system X-ag) in sinusoidal membranes of perfused 
rat liver (V,,, = 0.18 ~01 Glu/g per min, K,,, = 0.29 mM Glu). Tracer Glu transport was depressed 65% 
after necrosis of perivenous hepatocytes by acute CC& treatment, indicating that X-ag transporter activity 
is located mainly in these cells, the sites of glutamine (Gin) synthesis from glutamate and ammonia. Modula- 
tion of Glu transport may influence the extent of hepatic Gin release. 
Glutamine release; Glutamate transport; (Perivenous hepatocyte, Perfused liver) 
1. INTRODUCTION 
Glu and Gln metabolism in liver is spatially 
heterogeneous [l-3]. Periportal cells are the 
predominant site of glutaminase whereas 
glutamine synthetase is localised ‘downstream’ in 
perivenous hepatocytes, where it scavenges am- 
monia (Km about 0.1 mM [2]) escaping the urea cy- 
cle. Portal Glu is thus involved both in ammonia 
scavenging and in regulation of plasma Gln [l]. 
Glu transport in hepatocytes is well characteris- 
ed, two Na-dependent Glu transporters 
(glucocorticoid-inducible) having been identified 
[4,5]. Hepatocyte studies are incapable of 
distinguishing between either sinusoidal and bile- 
canalicular membrane transport, or relative 
periportal/perivenous contributions. The existence 
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or not of Glu transport in sinusoidal membrane 
vesicles is disputed [6,7], although in intact liver 
saturable uptake [S] and utilization [l] of portal 
Glu are clearly demonstrable. Little quantitative 
information exists on Glu transport in whole liver 
however, thus precluding direct assessment of 
possible transporter modulation of Glu flux 
through intra- and intercellular [2] metabolic 
pathways. We have therefore investigated Glu 
transport in the sinusoidal membrane of perfused 
rat liver by use of a paired-tracer isotope-dilution 
technique [9]. 
2. MATERIALS AND METHODS 
12-h fasted female Wistar rats (150-180 g body 
wt) were used. Selective perivenous liver cell 
necrosis was induced as required by administration 
of CC14 (2.5 ml/kg, 1 : 1 in olive oil [l]) via 
stomach tube 20 h before study. Livers of 
anaesthetised (60 mg/kg nembutal) rats were per- 
fused in situ via the hepatic portal vein (HPV) [lo]. 
The perfusate (Krebs-Henseleit buffer, pH 7.4, 
37”C, gassed with 95% 02/5% CO2, containing 
1% BSA (Miles fraction V) and 15% rejuvenated 
human red blood cells [l 11) was pumped without 
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recirculation at a physiological flow rate [12] of 
1.2kO.l ml/g liver per min (0). 
Unidirectional amino acid transport was 
measured by a rapid paired-tracer dilution techni- 
que [9]. 3H-labelled amino acid and 14C-labelled 
sucrose (extracellular marker: [13]) in 0.1 ml per- 
fusate (0.2 MBq total radioactivity: ‘H/14C dmp 
ratio of 5: 1) were injected as a bolus into HPV. 
HV effluent was collected over 2 min (0.2-ml ali- 
quots into 0.2 ml 10% PCA). 3H-tracer uptake by 
red cells was negligible over this period. Denatured 
perfusate protein was spun down and 0.12 ml 
supernatant was processed for dual-channel iquid 
scintillation counting (Beckman LS 1800) with 
automatic quench correction. Extracellular 14C- 
tracer recovery exceeded 95%. Isotope dilution 
profiles of the tracers (fig.la) yielded the time 
course of amino acid UFE; for each sample = 
1 - ((510 3H dose recovered/% 14C dose recovered). 
PS of the sinusoidal barrier was estimated from 
Umax as Qx - ln(1 - U,,,,,) [ 141. Unidirectional 
transport (J) was calculated as PS x perfusate 
[amino acid] and net hepatic amino acid flux as 
Qx ([amino acidh, - [amino acid]&, where 
[amino acid] represents the amino acid concentra- 
tion. The kinetics of Glu transport were character- 
ised by measuring tracer amino acid influx in 
perfusates containing 0.02-20 mM unlabelled 
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amino acid presented in random order. Tracer in- 
flux was measured over the final 2 min of 10 min 
exposure to each perfusate. I’,,,,, and K, values 
were obtained using iterative programs [15] on an 
Apple Ile microcomputer. 
Amino acid concentrations of deproteinised 
(20% sulphosalicylic acid) samples were measured 
by either automated amino acid analyser or stan- 
dard enzymatic methods [16]. Glutaminase and 
glutamine synthetase activity were measured in 
homogenised liver (100 mM KCI, 50 mM Tris-HCl 
buffer, pH 7.8), glutaminase as the rate of Glu 
production from 20 mM glutamine (pH 8.0, 
+ 10 mM phosphate [17]) and glutamine syn- 
thetase as the rate of [3H]Gln synthesis from . 
[3H]Glu (20 mM Glu, pH 7.4 [18]; Glu and Gln 
were separated by paper chromatography in 4: 1 
phenol-water). 
Results are presented as means f 1 SE. 
Statistical significances were assessed by Student’s 
t-test. 
3. RESULTS 
The mean Umax of tracer [3H]Glu, normally 0.44 
(e.g. fig.lb), fell to 0.06 in the presence of 20 mM 
unlabelled Glu and the hepatic PS product de- 
creased with increasing perfusate Glu concentra- 
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Fig.1. (a) Isotope dilution profiles in effluent from perfused liver after injection of [3H]glutamate + [‘4C]sucrose 
mixture into the portal circulation at 0.05 mM perfusate Glu. (b) Liver fractional extraction (UFE) of [3H]glutamate. 
Tracer uptake is depressed by increased perfusate amino acid concentrations. 
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Fig.2. (a) PS product and (b) influx of glutamate in 
perfused liver as a function of perfusate Glu 
concentration. (0) Control livers, (0) CC4-treated 
livers (n = 4-6). 
tion (fig.2a). Thus movement of Glu from blood to 
hepatocytes included a saturable mechanism. Glu 
influx considerably exceeded net hepatic flux, 
which was - 0.05 f 0.01 and +0.07 + 
O.O2,~mol/g per min at perfusate Glu of 0.02 and 
0.5 mM, respectively. In post-absorptive rats in 
vivo HPV plasma Glu was 0.075 f 0.011 mM (n = 
7). Co-injection of 50 mM unlabelled L-Glu, D- 
Glu, L-Asp, D-Asp and L-Gln with [3H]Glu tracer 
depressed the initial tracer extraction by a max- 
imum of 85 k 4, 8 f 7, 49 f 12, 61 f 9 and 4 + 
3 070, respectively (n = 3-4). Flux-concentration 
data were fitted to a first-order Michaelis-Menten 
function (J vs [Glu] to a hyperbola; PS vs ln[Glu] 
to an inverse sigmoid curve [19]), and kinetic 
characteristics were obtained for saturable Glu 
transport (V,,, = 0.18 f 0.03 pmol/g per min, Km 
= 0.29 + 0.11 mM). 
Glu influx was markedly depressed in 
CClJ-treated rats, tracer [3H]Glu extraction being 
reduced to 0.17 and influx to about 35% of normal 
over 0.02-0.5 mM Glu (fig.2). CCld-treated rat 
Table 1 
Glutaminase and glutamine synthetase activities in 
control livers and in those from rats treated with CCL 
(2.5 ml/kg) 
Enzyme Enzyme activity in liver 
homogenate &mol/g 
per min: n = 4-7) 
Control CCL-treated 
Glutaminase 5.78 + 0.73 4.94 + 0.56 
Glutamine synthetase 7.6 + 1.5 2.5 + 0.4sa 
a Significantly different from control value, p < 0.01 
About 60% of glutaminase activity was phosphate- 
dependent 
liver showed a 67% depletion of hepatic glutamine 
synthetase but no loss of glutaminase activity 
(table l), results consistent with selective necrosis 
of perivenous hepatocytes. Glutamine transport 
was unaffected by the treatment (mean unidirec- 
tional [3H]Gln extractions of 0.73 in both control 
and CCld-treated livers at 0.5 mM Gin [20]), in- 
dicating a specific loss of perivenous Glu-transport 
capacity. 
Limited substitution of perfusate Na+ (replace- 
ment of 118 mM NaCl by choline or NMDG 
chlorides, with retention of 25 mM NaHCO3) 
significantly reduced hepatic Glu and Gln influx 
(table 2). Ammonia (0.8 mM in perfusate) was 
without effect on Glu transport at 0.05 mM per- 
fusate Glu (not shown). 
4. DISCUSSION 
We have observed extractions of tracer Glu and 
Gln from portal perfusate during a single passage 
through liver sinusoids as high as those found 
previously in rat liver in vivo [21]. The results in- 
dicate that hepatocytes (which constitute 83% of 
liver mass [22]) in vivo extract Glu from the HPV 
by a low capacity, ‘high-affinity’ carrier-mediated 
process. L-Glu, L-Asp and D-Asp were effective 
inhibitors of [3H]Glu influx and, although com- 
petitive and non-competitive inhibition were not 
differentiated, previous studies show that these 
amino acids share a dicarboxylate transporter 
designated system X-ag [4,7]. At physiological 
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Table 2 
The effects of extracellular sodium replacement with choline or 
NMDG on glutamate and glutamine transport in perfused rat liver 
Amino acid Amino acid influx 
(umol/g per min: n = 4-5) 
Control Choline-Krebs NMDG-Krebs 
September 1987 
Glutamate 0.028 -t 0.003 0.008 + 0.002b 0.010 z!z 0.003b 
Glutamine 0.55 + 0.06 0.20 + 0.02b 0.34 + O.OSa 
Values significantly different from control, a p < 0.05; b p < 0.01 
amino acids share a dicarboxylate transporter 
designated system X-ag [4,7]. At physiological 
HPV plasma Glu, approx. 66% of Glu influx is in- 
to the small (7% by vol. [3]) population of 
perivenous hepatocytes, i.e. transport may be 
25times faster into perivenous cells than into 
periportal cells. The capacity of system X-ag is an 
order of magnitude lower than that of Na- 
dependent systems transporting Ala and Gin in 
perfused rat liver [12], but physiologically it will 
still extract about 34% of portal Glu during a 
single passage (0.075 mM Glu, 1.2 ml/g per min 
portal flow [12]). Residual Glu extraction in 
CCL-treated rat liver is low, indicating that 
periportal Glu exchange may be predominantly 
diffusional. 
HPV [14C]Glu is maximally utilized by perfused 
rat liver (yielding r4COz) at 0.2 pmol/g per min 
with a K, of about 0.15 mM [l]; these values are 
similar to the observed transport characteristics, 
indicating rapid turnover of the perivenous Glu 
pool. The good match between Glu entry and 
metabolism indicates that (i) little or no portal Glu 
is transported into the bile and (ii) there is likely to 
be no significant Glu efflux across perivenous 
sinusoidal membranes. 
Glu is simultaneously taken up and released by 
perfused liver [l]. Most Glu uptake is by 
perivenous cells which release no Glu, thus Glu ex- 
change (leading to net efflux) must occur across 
blood-facing membranes of periportal tissue. 
Periportal Glu accumulation is evident when 
mitochondrial glutaminase activity is stimulated in 
perfused liver [l], and one barrier to Glu export is 
likely to be the sinusoidal membrane. In this study 
hepatic Glu balance becomes positive as portal 
delivery increases due to a relative increase in 
perivenous extraction over periportal efflux. 
Glu and Asp have similar transport 
characteristics by system X-ag [7]. Surface mem- 
brane transport may be important for control of 
the intracellular concentrations of Glu and Asp, 
and possibly for regulating interaction between 
cytosol and mitochondria (e.g. [2]). Na-dependent 
transport permits cytosolic Glu to be maintained 
above the plasma concentration [5]. It has been 
argued that neither ammonia nor Glu availability 
exerts appreciable physiological control over 
perivenous Gln synthesis [2], although about 60% 
of transported Glu is available to glutamine syn- 
thetase. Nevertheless, the need for close co- 
ordination of Glu transport and Gln synthesis ap- 
pears to be exhibited by the finding that Glu 
transporters are induced in parallel with Gln syn- 
thetase by glucocorticoids in cultured hepatocytes 
[5,23]; thus Glu availability by transport may in- 
deed exert some control over Gln synthesis. 
The present results help explain apparently con- 
flicting reports on the localisation of Glu transport 
in liver plasma membrane (e.g. [5-71). There ap- 
pear to be two Na-dependent ransport systems on 
the hepatocyte membrane [4,5]: one is located on 
the bile-canalicular surface and has high substrate 
affinity (Km about lo-25 pM); the second, 
characterised here, is on the perivenous sinusoidal 
membrane and has slightly lower affinity (Km = 
0.29 mM). Masking of Glu transport activity in 
perivenous sinusoidal membranes by the larger 
pool of periportal membranes in hepatocytes and 
vesicle preparations may partly explain why the 
latter system has been overlooked in some previous 
studies (e.g. [6]). 
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